Literature DB >> 26714591

Authors' reply to 'Granulocytic myeloid-derived suppressor cells in peripheral blood of patients with cutaneous melanoma'.

Ivan Stanojevic1, Mirjana Djukic2, Danilo Vojvodic2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26714591      PMCID： PMC4885222          DOI： 10.1093/intimm/dxv078

Source DB:  PubMed          Journal:  Int Immunol        ISSN： 0953-8178            Impact factor:   4.823


× No keyword cloud information.
  5 in total

1.  In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.

Authors:  Jessica M Haverkamp; Scott A Crist; Bennett D Elzey; Cansu Cimen; Timothy L Ratliff
Journal:  Eur J Immunol       Date:  2011-02-02       Impact factor: 5.532

Review 2.  Immunophenotypic pattern of myeloid populations by flow cytometry analysis.

Authors:  Wojciech Gorczyca; Zhong-Yi Sun; William Cronin; Xiaoyu Li; Sophal Mau; Sorina Tugulea
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

3.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Authors:  J Schmielau; O J Finn
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma.

Authors:  Ivan Stanojevic; Karolina Miller; Lidija Kandolf-Sekulovic; Zeljko Mijuskovic; Lidija Zolotarevski; Milena Jovic; Milomir Gacevic; Mirjana Djukic; Nebojsa Arsenijevic; Danilo Vojvodic
Journal:  Int Immunol       Date:  2015-09-21       Impact factor: 4.823

5.  CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation.

Authors:  M A Shipp; G B Stefano; S N Switzer; J D Griffin; E L Reinherz
Journal:  Blood       Date:  1991-10-01       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.